Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biomarin
Biomarin
Biomarin Pharm Shares Downgraded by Zacks Investment Research to “Underperform” (BMRN)
Web Inquirer, UK
Sat, 02/11/12 - 12:53 pm
Biomarin
Don't Get Too Worked Up Over BioMarin Pharmaceutical's Earnings
Motley Fool
Fri, 02/3/12 - 09:55 am
earnings
Biomarin
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
10 Biotech Stock Predictions for 2012
TheStreet.com
Tue, 12/20/11 - 11:13 am
Amgen
FDA
Oncothyreon
Merck KGaA
Vical
GSK
Seattle Genetics
M&A
Celgene
Biomarin
Amag Pharmaceuticals
Momenta
ONYX Pharmaceuticals
Cell Therapeutics
Roche
Aeterna Zentaris
Arena Pharmaceuticals
Vertex
Spectrum Pharmaceuticals
FDA clears $60M BioMarin drug-making plant expansion
Bizjournals.com
Tue, 11/29/11 - 08:32 am
FDA
Biomarin
3 Rallying Healthcare Stocks With Bullish Short Trends
Seeking Alpha
Sun, 11/27/11 - 12:07 pm
Biomarin
Questcor Pharmaceuticals
Medivation
11 Biotech Stocks With Bullish Short Trends
Seeking Alpha
Wed, 11/23/11 - 11:14 am
Biomarin
BioSpecifics Technologies
Complete Genomics
Incyte
Medivation
Insmed
Momenta
Questcor
Seattle Genetics
Sangamo BioSciences
XenoPort
The 8 Highest Potential Returns in Biotechnology
Motley Fool
Mon, 10/17/11 - 07:33 pm
Biomarin
Emergent BioSolutions
United Therapeutics
Gilead
3SBio
Targacept
Amgen
Celgene
Top Mid- And Large-Cap Biotech Picks By Legendary Fund Managers
Seeking Alpha
Fri, 10/14/11 - 11:41 am
Alexion
Amgen
Amylin
Biogen Idec
Biomarin
Celgene
Gilead
Human Genome Sciences
Incyte
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Theravance
Relatively Low Operating Margin Detected in Shares of BioMarin Pharmaceutical in the Biotechnology Industry (BMRN, SUPG, ACOR, CPHD, GHDX)
Investor's Business Daily
Sun, 10/9/11 - 03:51 pm
Biomarin
Supergen
Acorda Therapeutics
Cepheid
Genomic Health
BioMarin Stock Hits New 52-Week High
The Street
Sat, 10/8/11 - 12:38 pm
Biomarin
5 Biotech Stocks Seeing Significant Short Covering
Seeking Alpha
Tue, 10/4/11 - 12:28 pm
Biocryst
BioDelivery Sciences
Cephalon
Biomarin
Immunogen
BioMarin Evenly Poised
Yahoo/Zacks.com
Wed, 09/7/11 - 01:06 pm
Biomarin
Pfizer
Sanofi
Kuvan
Aldurazyme
Naglazyme
Firdapse
The Mystery of BioMarin
Minyanville
Tue, 08/30/11 - 07:05 pm
Biomarin
Biotech Stocks Pains Continue As Outflows Persist
Forbes
Mon, 08/22/11 - 11:59 am
Biomarin
Regeneron
Spectrum
Revenues Rise at BioMarin
Zacks
Sat, 07/30/11 - 10:25 am
Biomarin
earnings
Revenues Rise at BioMarin
Yahoo/Zacks
Sat, 07/30/11 - 09:39 am
Biomarin
10 Biotech Takeover/LBO Targets With Bullish Options Sentiment
Seeking Alpha
Thu, 07/21/11 - 12:21 pm
M&A
Chelsea Therapeutics
Amgen
Human Genome Sciences
Acorda Therapeutics
Celgene
Dendreon
InterMune
Biomarin
Alnylam
Exelixis
BioMarin Starts Study on BMN673
Yahoo/Zacks
Sat, 07/16/11 - 11:36 am
Biomarin
BMN673
leukemia
lymphoma
myelodysplastic syndrome
8 Potential Biotech Acquisition Candidates
Seeking Alpha
Mon, 06/20/11 - 09:30 am
biotech
M&A
Arena Pharmaceuticals
Biomarin
Dendreon
Human Genome Sciences
Keryx
MannKind
Novartis
Orexigen
Vivus
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
next ›
last »